{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:33:52Z","timestamp":1740123232686,"version":"3.37.3"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T00:00:00Z","timestamp":1631491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T00:00:00Z","timestamp":1631491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Glycoconj J"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s10719-021-10016-w","type":"journal-article","created":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T08:03:02Z","timestamp":1631520182000},"page":"539-549","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and Immunogenicity of a Brazilian Glycoconjugate vaccine against Meningococcal W in a Pilot Scale"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5318-2421","authenticated-orcid":false,"given":"Iaralice Medeiros","family":"de Souza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milton Neto","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata Chagas","family":"Bastos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise da Silva Gomes","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elza Cristina Schott","family":"Figueira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Jessouroun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria de Lourdes Moura","family":"Leal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliana","family":"Barreto-Bergter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivna Alana Freitas Brasileiro","family":"da Silveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,13]]},"reference":[{"key":"10016_CR1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268812001689","author":"MA S\u00e1fadi","year":"2013","unstructured":"S\u00e1fadi, M.A., Gonz\u00e1lez-Ayala, S., J\u00e4kel, A., Wieffer, H., Moreno, C., Vyse, A.: The epidemiology of meningococcal disease in Latin America 1945\u20132010: an unpredictable and changing landscape. Epidemiol Infect. (2013). https:\/\/doi.org\/10.1017\/S0950268812001689","journal-title":"Epidemiol Infect."},{"key":"10016_CR2","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1532248","author":"R Booy","year":"2019","unstructured":"Booy, R., Gentile, A., Nissen, M., Whelan, J., Abitbol, V.: Recent changes in the epidemiology of Neisseria meningitidis serogroup W across the world, current vaccination policy choices and possible future strategies. Hum Vaccin Immunother. (2019). https:\/\/doi.org\/10.1080\/21645515.2018.1532248","journal-title":"Hum Vaccin Immunother."},{"key":"10016_CR3","doi-asserted-by":"publisher","DOI":"10.1586\/erv.10.120","author":"YL Huang","year":"2010","unstructured":"Huang, Y.L., Wu, C.Y.: Carbohydrate-based vaccines: challenges and opportunities. Expert Rev Vaccines (2010). https:\/\/doi.org\/10.1586\/erv.10.120","journal-title":"Expert Rev Vaccines"},{"key":"10016_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s10719-021-09990-y","author":"F Berti","year":"2021","unstructured":"Berti, F., Romano, M.R., Micoli, F., Adamo, R.: Carbohydrate based meningococcal vaccines: past and present overview. Glycoconj J. (2021). https:\/\/doi.org\/10.1007\/s10719-021-09990-y","journal-title":"Glycoconj J."},{"key":"10016_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.04.038","author":"B Koumar\u00e9","year":"2007","unstructured":"Koumar\u00e9, B., Ouedraogo-Traor\u00e9, R., Sanou, I., Yada, A.A., Sow, I., Lusamba, P.S., Traor\u00e9, E., Dabal, M., Santamaria, M., Hacen, M.M., Kabor\u00e9, A.B., Caugant, D.A.: The first large epidemic of meningococcal disease caused by serogroup W135, Burkina Faso, 2002. Vaccine (2007). https:\/\/doi.org\/10.1016\/j.vaccine.2007.04.038","journal-title":"Vaccine"},{"key":"10016_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2009.11.014","author":"AP Lemos","year":"2010","unstructured":"Lemos, A.P., Harrison, L.H., Lenser, M., Sacchi, C.T.: Phenotypic and molecular characterization of invasive serogroup W135 Neisseria meningitidis strains from 1990 to 2005 in Brazil. J Infect. (2010). https:\/\/doi.org\/10.1016\/j.jinf.2009.11.014","journal-title":"J Infect."},{"key":"10016_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2013.01.002","author":"DE Barroso","year":"2013","unstructured":"Barroso, D.E., Casti\u00f1eiras, T.M., Cabral, A.C., Vicente, A.C., Rebelo, M.C., Cerqueira, E.O., Tulenko, M.M., Marsh, J.W., Krauland, M.G., Harrison, L.H.: Neisseria meningitidis ST-11 clonal complex bearing capsule serogroups B, C, or W in Brazil. The J infect (2013). https:\/\/doi.org\/10.1016\/j.jinf.2013.01.002","journal-title":"The J infect"},{"key":"10016_CR8","doi-asserted-by":"publisher","unstructured":"Retchless, A., Hu, F., Ou\u00e9draogo, A., Diarra, S., Knipe, K., Sheth, M., Rowe, L., Sangar\u00e9, L., Ky Ba, A., Ouangraoua, S., Batra, D., Novak, R., Ou\u00e9draogo Traor\u00e9, R., & Wang, X.: The establishment and diversification of epidemic-associated serogroup W meningococcus in the African meningitis belt, 1994 to 2012. mSphere (2016). https:\/\/doi.org\/10.1128\/mSphere.00201-16","DOI":"10.1128\/mSphere.00201-16"},{"key":"10016_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2015.07.007","author":"J Lucidarme","year":"2015","unstructured":"Lucidarme, J., Hill, D.M., Bratcher, H.B., Gray, S.J., du Plessis, M., Tsang, R.S., Vazquez, J.A., Taha, M.K., Ceyhan, M., Efron, A.M., Gorla, M.C., Findlow, J., Jolley, K.A., Maiden, M.C., Borrow, R.: Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B. C and W lineage. J Infect (2015). https:\/\/doi.org\/10.1016\/j.jinf.2015.07.007","journal-title":"C and W lineage. J Infect"},{"key":"10016_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu881","author":"SN Ladhani","year":"2015","unstructured":"Ladhani, S.N., Beebeejaun, K., Lucidarme, J., Campbell, H., Gray, S., Kaczmarski, E., Ramsay, M.E., Borrow, R.: Increase in endemic Neisseria meningitidis capsular group W sequence type 11 complex associated with severe invasive disease in England and Wales. Clin Infect Dis (2015). https:\/\/doi.org\/10.1093\/cid\/ciu881","journal-title":"Clin Infect Dis"},{"key":"10016_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.05.079","author":"SR Parikh","year":"2020","unstructured":"Parikh, S.R., Campbell, H., Bettinger, J.A., Harrison, L.H., Marshall, H.S., Martinon-Torres, F., Safadi, M.A., Shao, Z., Zhu, B., von Gottberg, A., Borrow, R., Ramsay, M.E., Ladhani, S.N.: The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination. J Infect. (2020). https:\/\/doi.org\/10.1016\/j.jinf.2020.05.079","journal-title":"J Infect."},{"key":"10016_CR12","doi-asserted-by":"publisher","unstructured":"Aparecido Nunes, A., De Jesus Lopes De Abreu, A., Cintra, O., A C T Cintra, M., Barbosa Coelho, E., & Nogueira Castro De Barros, E.: Meningococcal disease epidemiology in Brazil (2005\u20132018) and impact of MenC vaccination.\u00a0Vaccine (2021). https:\/\/doi.org\/10.1016\/j.vaccine.2020.11.067","DOI":"10.1016\/j.vaccine.2020.11.067"},{"key":"10016_CR13","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2016.21.12.30175","author":"H Campbell","year":"2016","unstructured":"Campbell, H., Parikh, S.R., Borrow, R., Kaczmarski, E., Ramsay, M.E., Ladhani, S.N.: Presentation with gastrointestinal symptoms and high case fatality associated with group W meningococcal disease (MenW) in teenagers, England, July 2015 to January 2016. Euro surveil. (2016). https:\/\/doi.org\/10.2807\/1560-7917.ES.2016.21.12.30175","journal-title":"Euro surveil."},{"key":"10016_CR14","unstructured":"SIREVA.: Organizacion Panamericana de la salud, informe regional Sireva, 2017, Brasil. Informa\u00e7\u00e3o da vigil\u00e2ncia das pneumonias e meningites bacterianas (2017). https:\/\/www.saude.pr.gov.br\/sites\/default\/arquivos_restritos\/files\/documento\/2020-04\/sireva_2017_2.pdf\u00a0(2021). Accessed 07 May 2021."},{"key":"10016_CR15","doi-asserted-by":"publisher","DOI":"10.1039\/c8cs00495a","author":"F Berti","year":"2018","unstructured":"Berti, F., Adamo, R.: Antimicrobial glycoconjugate vaccines: an overview of classic and modern approaches for protein modification. Chem Soc Rev. (2018). https:\/\/doi.org\/10.1039\/c8cs00495a","journal-title":"Chem Soc Rev."},{"key":"10016_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.07.037","author":"IA Silveira","year":"2007","unstructured":"Silveira, I.A., Bastos, R.C., Neto, M.S., Laranjeira, A.P., Assis, E.F., Fernandes, S.A., Leal, M.L., Silva, W.C., Lee, C.H., Frasch, C.E., Peralta, J.M., Jessouroun, E.: Characterization and immunogenicity of meningococcal group C conjugate vaccine prepared using hydrazide-activated tetanus toxoid. Vaccine (2007). https:\/\/doi.org\/10.1016\/j.vaccine.2007.07.037","journal-title":"Vaccine"},{"key":"10016_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.03.097","author":"RC Bastos","year":"2015","unstructured":"Bastos, R.C., de Souza, I.M., da Silva, M.N., Silva, F., Figueira, E.S., Leal, M., Jessouroun, E., da SilvaMedronho, J.G.R., Jr., da Silveira, I.A.: Brazilian meningococcal C conjugate vaccine: Scaling up studies. Vaccine (2015). https:\/\/doi.org\/10.1016\/j.vaccine.2015.03.097","journal-title":"Vaccine"},{"key":"10016_CR18","doi-asserted-by":"publisher","unstructured":"Svennerholm, L.: Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method.\u00a0Biochim Biophys Acta 24(3):604\u2013611 (1957). https:\/\/doi.org\/10.1016\/0006-3002(57)90254-8","DOI":"10.1016\/0006-3002(57)90254-8"},{"key":"10016_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s10295-008-0428-4","author":"M Takagi","year":"2008","unstructured":"Takagi, M., Lima, R.B., Albani, S.M., Zangirolami, T.C., Tanizaki, M.M., Cabrera-Crespo, J.: Purification of capsular polysaccharide produced by Haemophilus influenzae type b through a simple, efficient and suitable method for scale-up. J Ind Microbiol Biotechnol (2008). https:\/\/doi.org\/10.1007\/s10295-008-0428-4","journal-title":"J Ind Microbiol Biotechnol"},{"key":"10016_CR20","unstructured":"Gill, D., Chhikara, M.K., Sharma, S., Hanif, S., Joshi., N.: A novel downstream process for purifying polysaccharides US10011662B2 (2015). https:\/\/patents.google.com\/patent\/US10011662B2\/en (2021). Accessed 07 May 2021."},{"key":"10016_CR21","unstructured":"WHO.: Annex 6. Requirements for meningococcal polysaccharide vaccine. In: WHO Requirements for biological substances no. 23: Addendum 1980. (1980). https:\/\/www.who.int\/biologicals\/publications\/trs\/areas\/vaccines\/meningococcal\/WHO_TRS_658_(part2)_MeningA6.pdf?ua=1 (2021). Accessed 07 May 2021."},{"key":"10016_CR22","doi-asserted-by":"publisher","unstructured":"Bastos, R. C., Corr\u00eaa, M. B., de Souza, I. M., da Silva, M. N., da Silva Gomes Pereira, D., Martins, F. O., da Silva Faria, C., Ano Bom, A., de Lourdes Leal, M., Jessouroun, E., da Silva, J. G., Jr, de Andrade Medronho, R., & da Silveira, I.: Brazilian meningococcal C conjugate vaccine: physicochemical, immunological, and thermal stability characteristics. Glycoconj J (2018). https:\/\/doi.org\/10.1007\/s10719-017-9787-2","DOI":"10.1007\/s10719-017-9787-2"},{"key":"10016_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.06.013","author":"CE Frasch","year":"2009","unstructured":"Frasch, C.E.: Preparation of bacterial polysaccharide-protein conjugates: analytical and manufacturing challenges. Vaccine (2009). https:\/\/doi.org\/10.1016\/j.vaccine.2009.06.013","journal-title":"Vaccine"},{"key":"10016_CR24","unstructured":"Jessouorun, E., Silveira, I. A. F. B., Bastos, R. C., Frasch, C. E.,Lee, C.-H.: Process for preparing polysaccharide-protein conjugate vaccines. Patent Number WO\/2005\/037320 (2005) https:\/\/patentscope.wipo.int\/search\/en\/detail.jsf?docId=WO2005037320 (2021). Accessed 07 May 2021"},{"key":"10016_CR25","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J.: Protein measurement with the Folin phenol reagent. J Biol Chem 193, 265\u2013275 (1951)","journal-title":"J Biol Chem"},{"key":"10016_CR26","doi-asserted-by":"publisher","DOI":"10.1128\/iai.71.9.5115-5120.2003","author":"Z Jin","year":"2003","unstructured":"Jin, Z., Chu, C., Robbins, J.B., Schneerson, R.: Preparation and characterization of group A meningococcal capsular polysaccharide conjugates and evaluation of their immunogenicity in mice. Infect Immun (2003). https:\/\/doi.org\/10.1128\/iai.71.9.5115-5120.2003","journal-title":"Infect Immun"},{"key":"10016_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.06.018","author":"SK Gudlavalleti","year":"2007","unstructured":"Gudlavalleti, S.K., Lee, C.H., Norris, S.E., Paul-Satyaseela, M., Vann, W.F., Frasch, C.E.: Comparison of Neisseria meningitidis serogroup W135 polysaccharide-tetanus toxoid conjugate vaccines made by periodate activation of O-acetylated, non-O-acetylated and chemically de-O-acetylated polysaccharide. Vaccine (2007). https:\/\/doi.org\/10.1016\/j.vaccine.2007.06.018","journal-title":"Vaccine"},{"key":"10016_CR28","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.4049\/jimmunol.127.3.1011","volume":"127","author":"HJ Jennings","year":"1981","unstructured":"Jennings, H.J., Lugowski, C.: Immunochemistry of groups A, B, and C meningococcal polysaccharide-tetanus toxoid conjugates. J Immunol 127, 1011\u20131018 (1981)","journal-title":"J Immunol"},{"key":"10016_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/s0731-7085(02)00462-4","author":"C Jones","year":"2002","unstructured":"Jones, C., Lemercinier, X.: Use and validation of NMR assays for the identity and O-acetyl content of capsular polysaccharides from Neisseria meningitidis used in vaccine manufacture. J Pharm Biomed Anal (2002). https:\/\/doi.org\/10.1016\/s0731-7085(02)00462-4","journal-title":"J Pharm Biomed Anal"},{"key":"10016_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/elps.201300298","author":"IM Souza","year":"2013","unstructured":"Souza, I.M., Silva, M.N., Figueira, E.S., Leal, M., Jessouroun, E., Abrantes, S.P., Silveira, I.A.B.: Single validation of CE method for determining free polysaccharide content in a Brazilian meningococcal C conjugate vaccine. Electrophoresis (2013). https:\/\/doi.org\/10.1002\/elps.201300298","journal-title":"Electrophoresis"},{"key":"10016_CR31","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.32.6.1475-1482.1994","author":"LL Gheesling","year":"1994","unstructured":"Gheesling, L.L., Carlone, G.M., Pais, L.B., Holder, P.F., Maslanka, S.E., Plikaytis, B.D., Achtman, M., Densen, P., Frasch, C.E., K\u00e4yhty, H.: Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay. J Clin Microbiol (1994). https:\/\/doi.org\/10.1128\/JCM.32.6.1475-1482.1994","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10016_CR32","first-page":"31","volume":"21","author":"B Cedr\u00e9-Marrero","year":"2012","unstructured":"Cedr\u00e9-Marrero, B., Hern\u00e1ndez, Y., Delgado, I., Izquierdo, L., Garc\u00eda-Imia, L.: Validaci\u00f3n del ensayo bactericida en suero para los serogrupos A, C y W135 de Neisseria meningitidis. VacciMonitor 21(2), 31\u201334 (2012)","journal-title":"VacciMonitor"},{"key":"10016_CR33","unstructured":"Madariaga, S.,\u00a0Cedr\u00e9, B.,\u00a0Garc\u00eda, M., Gonz\u00e1lez, E.,\u00a0Ferro, V.A.,\u00a0&\u00a0Acevedo, R.: Evaluation of bactericidal activity of monoclonal antibodies obtained from Neisseria meningitidis. Clin Infect Dis. 2(3), 115 (2018)"},{"issue":"7","key":"10016_CR34","doi-asserted-by":"publisher","first-page":"12827","DOI":"10.1021\/acsomega.9b01678","volume":"4","author":"S Martini","year":"2019","unstructured":"Martini, S., Aggravi, M., Cianetti, S., Egan, W., Meppen, M., Moriconi, A., Simeone, L., Berti, F.: NMR Assays for Estimating the O-Acetyl Content of Meningococcal Polysaccharide Serogroup A in Quadrivalent Conjugate Vaccine Formulation. ACS Omega 4(7), 12827\u201312832 (2019). https:\/\/doi.org\/10.1021\/acsomega.9b01678","journal-title":"ACS Omega"},{"key":"10016_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s10719-011-9344-3","author":"C Laferriere","year":"2011","unstructured":"Laferriere, C., Ravenscroft, N., Wilson, S., Combrink, J., Gordon, L., Petre, J.: Experimental design to optimize an Haemophilus influenzae type b conjugate vaccine made with hydrazide-derivatized tetanus toxoid. Glycoconj J (2011). https:\/\/doi.org\/10.1007\/s10719-011-9344-3","journal-title":"Glycoconj J"},{"key":"10016_CR36","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2006.111500","author":"D Pace","year":"2007","unstructured":"Pace, D., Pollard, A.J.: Meningococcal A, C, Y and W-135 polysaccharide-protein conjugate vaccines. Arch Dis Child (2007). https:\/\/doi.org\/10.1136\/adc.2006.111500","journal-title":"Arch Dis Child"},{"key":"10016_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3194","author":"L Harrison","year":"2010","unstructured":"Harrison, L., Mohan, N., Kirkpatrick, P.: Meningococcal group A, C, Y and W-135 conjugate vaccine. Nat Rev Drug Discov (2010). https:\/\/doi.org\/10.1038\/nrd3194","journal-title":"Nat Rev Drug Discov"},{"key":"10016_CR38","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2016.1143157","author":"A Assaf-Casals","year":"2016","unstructured":"Assaf-Casals, A., Dbaibo, G.: Meningococcal quadrivalent tetanus toxoid conjugate vaccine (MenACWY-TT, NimenrixTM): A review of its immunogenicity, safety, co-administration, and antibody persistence. Hum Vaccin Immunother (2016). https:\/\/doi.org\/10.1080\/21645515.2016.1143157","journal-title":"Hum Vaccin Immunother"},{"key":"10016_CR39","unstructured":"WHO.: Annex 2 recommendations for the production and control of meningococcal group C conjugate vaccines. In: WHO Technical Report Series No.924. WHO Press, Genebra, Switzerland (2004). https:\/\/cdn.who.int\/media\/docs\/default-source\/biologicals\/vaccine-quality\/recommendations-for-the-production-and-control-of-meningococcal-group-c-conjugate-vaccines-trs-924-2004-annex-29ce33cc6-3572-4501-bdf3-671c2a4d358d.pdf?sfvrsn=2c14e0a2_1&download=true (2021). Accessed 07 May 2021."},{"key":"10016_CR40","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268814001149","author":"R Abad","year":"2014","unstructured":"Abad, R., L\u00f3pez, E.L., Debbag, R., V\u00e1zquez, J.A.: Serogroup W meningococcal disease: global spread and current affect on the Southern Cone in Latin America. Epidemiol Infect (2014). https:\/\/doi.org\/10.1017\/S0950268814001149","journal-title":"Epidemiol Infect"},{"key":"10016_CR41","doi-asserted-by":"publisher","unstructured":"Silveira, M. M., McBride, A., & Trotter, C.: Invasive Meningococcal Disease in Brazil: a literature review.\u00a0Vittalle - Revista de Ci\u00eancias da Sa\u00fade\u00a0(2020). https:\/\/doi.org\/10.14295\/vittalle.v32i1.9645","DOI":"10.14295\/vittalle.v32i1.9645"},{"key":"10016_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.05.079","author":"SR Parikh","year":"2020","unstructured":"Parikh, S.R., Campbell, H., Bettinger, J.A., Harrison, L.H., Marshall, H.S., Martinon-Torres, F., Safadi, M.A., Shao, Z., Zhu, B., von Gottberg, A., Borrow, R., Ramsay, M.E., Ladhani, S.N.: The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination. J Infect (2020). https:\/\/doi.org\/10.1016\/j.jinf.2020.05.079","journal-title":"J Infect"},{"key":"10016_CR43","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1593082","author":"J Findlow","year":"2019","unstructured":"Findlow, J., Balmer, P., Borrow, R.: A review of complement sources used in serum bactericidal assays for evaluating immune responses to meningococcal ACWY conjugate vaccines. Hum Vaccin Immunother (2019). https:\/\/doi.org\/10.1080\/21645515.2019.1593082","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"10016_CR44","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1128\/CDLI.12.5.586-592.2005","volume":"12","author":"PC Giardina","year":"2005","unstructured":"Giardina, P.C., Longworth, E., Evans-Johnson, R.E., Bessette, M.L., Zhang, H., Borrow, R., Madore, D., Fernsten, P.: Analysis of human serum immunoglobulin G against O-acetyl-positive and O-acetyl-negative serogroup W135 meningococcal capsular polysaccharide. Clin Diagn Lab Immunol 12(5), 586\u2013592 (2005). https:\/\/doi.org\/10.1128\/CDLI.12.5.586-592.2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"10016_CR45","doi-asserted-by":"publisher","DOI":"10.4161\/hv.19619","author":"CE Frasch","year":"2012","unstructured":"Frasch, C.E., Preziosi, M.P., LaForce, F.M.: Development of a group A meningococcal conjugate vaccine, MenAfriVac(TM). Hum Vaccin Immunother (2012). https:\/\/doi.org\/10.4161\/hv.19619","journal-title":"Hum Vaccin Immunother"},{"key":"10016_CR46","unstructured":"Hronowski, L.J.J., Mates, S., Tai, J.Y.: Vaccines against group C Neisseria meningitidis. US9308155W (1993) https:\/\/worldwide.espacenet.com\/patent\/search\/family\/026744584\/publication\/WO9405325A1?q=US9308155W (2021). Accessed 02 July 2021."},{"key":"10016_CR47","unstructured":"Stoudt, T.H., Carlo, D.J., Hagopian, A.: High molecular weight meningococcal group C vaccine and method for preparation thereof. US4235994A (1978). https:\/\/www.lens.org\/lens\/patent\/US_4235994_A (2021). Accessed 07 May 2021."},{"key":"10016_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.03.066","author":"NJ Beresford","year":"2017","unstructured":"Beresford, N.J., Martino, A., Feavers, I.M., Corbel, M.J., Bai, X., Borrow, R., Bolgiano, B.: Quality, immunogenicity and stability of meningococcal serogroup ACWY-CRM197. DT and TT glycoconjugate vaccines. Vaccine (2017). https:\/\/doi.org\/10.1016\/j.vaccine.2017.03.066","journal-title":"DT and TT glycoconjugate vaccines. Vaccine"},{"key":"10016_CR49","unstructured":"WHO.: Annex 2. Requirements for meningococcal polysaccharide vaccine. In: WHO Requirements for Biologicals Substance No 23. WHO Press, Genebra, Switzerland (1975). https:\/\/www.who.int\/publications\/m\/item\/requirements-for-meningococcal-polysaccharide-vaccine-adopted-1975-trs-594-annex-2 (2021). Accessed 07 May 2021."},{"key":"10016_CR50","doi-asserted-by":"publisher","DOI":"10.1006\/biol.2000.0253","author":"L Jodar","year":"2000","unstructured":"Jodar, L., Cartwright, K., Feavers, I.M.: Standardisation and validation of serological assays for the evaluation of immune responses to Neisseria meningitidis serogroup A and C vaccines. Biologicals (2000). https:\/\/doi.org\/10.1006\/biol.2000.0253","journal-title":"Biologicals"},{"key":"10016_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/s0264-410x(02)00625-4","author":"JY Wang","year":"2003","unstructured":"Wang, J.Y., Chang, A.H., Guttormsen, H.K., Rosas, A.L., Kasper, D.L.: Construction of designer glycoconjugate vaccines with size-specific oligosaccharide antigens and site-controlled coupling. Vaccine (2003). https:\/\/doi.org\/10.1016\/s0264-410x(02)00625-4","journal-title":"Vaccine"}],"container-title":["Glycoconjugate Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10719-021-10016-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10719-021-10016-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10719-021-10016-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T02:00:30Z","timestamp":1673229630000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10719-021-10016-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,13]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["10016"],"URL":"https:\/\/doi.org\/10.1007\/s10719-021-10016-w","relation":{},"ISSN":["0282-0080","1573-4986"],"issn-type":[{"type":"print","value":"0282-0080"},{"type":"electronic","value":"1573-4986"}],"subject":[],"published":{"date-parts":[[2021,9,13]]},"assertion":[{"value":"23 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal protocols were submitted and approved by the Oswaldo Cruz Foundation Ethical Committee with licenses numbers LW-65\/14 and LW-3\/20.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors have consented to publish this material.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest to declare that are relevant to the content of this article.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}